WSTAM
BLUE

Wilbanks Smith & Thomas Asset Management’s bluebird bio BLUE Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed -$3K – 468
2018
Q3 		$3K Buy
+2
New +$4.13K ﹤0.01% 1315

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's BLUE Position: Q4 2018 in Review

Wilbanks Smith & Thomas Asset Management sold out of bluebird bio (BLUE) in Q4 2018, closing a stake of 2 shares — an estimated $3K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in BLUE in Q3 2018 and held it in 1 quarter. The position peaked at $3K in Q3 2018. 251 funds tracked by Wall St. Rank hold BLUE as of Q4 2018.

  • Wilbanks Smith & Thomas Asset Management reported no remaining bluebird bio position as of Q4 2018 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 2 bluebird bio shares in Q4 2018, an estimated $3K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in bluebird bio in Q3 2018 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's bluebird bio position peaked at $3K in Q3 2018.
  • 251 funds tracked by Wall St. Rank held bluebird bio as of Q4 2018.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q4 2018, filed 8 Feb 2019.